Ekso Bionics Holdings Inc. experienced a significant price increase of 43.22%, reaching a 20-day high following the announcement of a proposed merger with Applied Digital.
The surge is attributed to the merger agreement reached between Applied Digital and EKSO to form ChronoScale, which will focus on AI workloads. This strategic move is expected to enhance competitive positioning in a rapidly growing market, reflecting strong market optimism regarding the merger's prospects.
This merger is anticipated to create a high-performance compute platform, leveraging Applied Digital's existing revenue foundation, which generated approximately $75.2 million in the past year. The merger is expected to drive EKSO's strategic growth and maximize shareholder value.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
